India’s electronics and pharmaceutical sectors have received the largest share of disbursements under the Production-Linked Incentive (PLI) scheme in the financial year 2024–25, accounting for nearly 70 percent of the total Rs 10.11 billion released during the period, according to official government data.
The electronics sector secured Rs 5.73 billion, positioning itself as the scheme’s leading beneficiary. With strong manufacturing incentives in place, electronics has surged into India’s top three export categories. The sector recorded a 32.46 percent growth in FY25, with outbound shipments rising from USD 29.12 billion in FY24 to USD 38.58 billion—more than doubling its value from USD 15.7 billion in FY22.
Notably, computer hardware and peripherals posted a 101 percent spike in exports, increasing from USD 0.7 billion to USD 1.4 billion. Key markets included the United Arab Emirates, the United States, the Netherlands, the United Kingdom and Italy.
The pharmaceutical sector received Rs 2.33 billion under the PLI scheme and registered a nearly 10 percent growth in exports, reaching USD 30.5 billion in FY25. India’s pharma products are now supplied to over 200 countries, reinforcing its global role in healthcare and medicines.
Launched in 2021 for 14 strategic industries, the PLI scheme was designed to strengthen India’s domestic manufacturing base and encourage higher value-added exports. The latest data underscores its success in boosting industrial competitiveness and positioning India as a global hub for electronics and pharmaceuticals.
